• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
FU Donglin, RAO Xuemin, XU Jinyi, XIE Weijia, WU Xiaoming. Total synthesis of cyclodepsipeptide Hikiamides A-C[J]. Journal of China Pharmaceutical University, 2018, 49(2): 181-186. DOI: 10.11665/j.issn.1000-5048.20180207
Citation: FU Donglin, RAO Xuemin, XU Jinyi, XIE Weijia, WU Xiaoming. Total synthesis of cyclodepsipeptide Hikiamides A-C[J]. Journal of China Pharmaceutical University, 2018, 49(2): 181-186. DOI: 10.11665/j.issn.1000-5048.20180207
shu

Total synthesis of cyclodepsipeptide Hikiamides A-C

More Information
    Graphical Abstract
    • Abstract
  • Total synthesis of cyclodepsipeptide Hikiamides A - C was described. Fragment convergent condensation method was applied for the preparation of Hikiamides A - C , starting from Commercially available amino acid such as L-N-Boc-Phe-OH, L-N-Boc-Trp-OH, L-N-Cbz-Van-OH etc. Tripeptide fragments(compounds 5a / 5b )and dipeptide fragments(compounds 8a / 8b )were first prepared. The subsequent condensation of the resulted two fragments provided protected linear pentapetides(compounds 9a / 9b / 9c ); Finally, the linear pentapetide was cyclized by a mixed condensing agents comprised of PyBOP and HBTU. Hikiamides A - C was obtained with total yields of 9%, 11% and 6. 5%, respectively. Compared with the natural source, this method has the advantages of low cost, convenient operation and high yield, which effectively solves the problem of low isolated yield of Hikiamides A - C from Fusarium sp.
    • FullText(HTML)
    • References (17)
  • [1]
    Wang T,Yin XX.Advances in therapeutics of type 2 diabetes mellitus[J].Prog Pharm Sci(药学进展),2016,40(5):323-330.
    [2]
    Zhao Y,Lin W,Li Z,et al.High expression of mannose-binding lectin and the risk of vascular complications of diabetes:evidence from a meta-analysis[J].Diabetes Technol Ther,2015,17(7):490-497.
    [3]
    Zhu XW,Deng FY,Wu LF,et al.Functional mechanisms for type 2 diabetes-associated genetic variants[J].J Diabetes Complicat,2015,29(4):497-501.
    [4]
    Seuring T,Archangelidi O,Suhrcke M.The economic costs of type 2 diabetes:a global systematic review[J].Pharmaco Economics,2015,33(8):811-831.
    [5]
    Poomalar GK.Changing trends in management of gestational diabetes mellitus[J].World J Diabetes,2015,6(2):284-295.
    [6]
    Gross B,Staels B.PPAR agonists:multimodal drugs for the treatment of type-2 diabetes[J].Best Pract Res Clin Endocrinol Metab,2007,21(4):687-710.
    [7]
    Schernthaner G,Currie CJ,Schernthaner GH.Do we still need pioglitazone for the treatment of type 2 diabetes? A risk-benefit critique in 2013[J].Dibetes Care,2013,36(2):155-160.
    [8]
    Fukuda T,Sudoh Y,Tsuchiya Y,et al.Hikiamides A-C,cyclic pentadepsipeptides from fusarium sp.tama 456[J].J Nat Prod,2015,78(4):797-802.
    [9]
    Gleeson EC,Jackson WR,Robinson AJ.Ring-closing metathesis in peptides[J].Tetrahedron Lett,2016,57(39):4325-4333.
    [10]
    Pan ZY,Wu CL,Wang W,et al.Total synthesis and stereochemical assignment of gymnopeptides A and B[J].Org Lett,2017,19(17):4420-4423.
    [11]
    Zhang S,Amso Z,Kaur H,et al.Synthesis of natural cyclopentapeptides isolated from dianthus chinensis[J].J Nat Prod,2016,79(7):1769-1774.
    [12]
    Scherkenbeck J,Lüttenberg S,Ludwig M,et al.Segment solid-phase total synthesis of the anthelmintic cyclooctadepsipeptides PF1022A and emodepside[J].Eur J Org Chem,2012,2012(8):1546-1553.
    [13]
    Maharani R,Brownlee RTC,Hughes AB,et al.A total synthesis of a highly N-methylated cyclodepsipeptide [2s,3s-Hmp]-aureobasidin l using solid-phase methods[J].Tetrahedron,2014,70(14):2351-2358.
    [14]
    He W,Qiu HB,Chen YJ,et al.Total synthesis of proposed structure of coibamide a,a highly N- and O-methylated cytotoxic marine cyclodepsipeptide[J].Tetrahedron Lett,2014,55(44):6109-6112.
    [15]
    Elagawany M,Ibrahim MA.An improved route for the synthesis of rolloamide B[J].Tetrahedron Lett,2016,57(34):3837-3840.
    [16]
    Carroll CL,Johnston JV,Kekec A,et al.Synthesis and cytotoxicity of novel sansalvamide A derivatives[J].Org Lett,2005,7(16):3481-3484.
    [17]
    Rodriguez RA,Pan PS,Pan CM,et al.Synthesis of second-generation sansalvamide A derivatives:novel templates as potential antitumor agents[J].J Org Chem,2007,72(6):1981-1987.
    • Related Articles

  • Related Articles

    [1]SUN Liting, ZHANG Weiguo, TONG Yue. Research progress on targeted protein S-palmitoylation modification in T cell immunotherapy[J]. Journal of China Pharmaceutical University, 2024, 55(1): 45-52. DOI: 10.11665/j.issn.1000-5048.2023112903
    [2]WANG Zhenghao, GAO Yafeng, ZHANG Lianjun, LIU Chang. Research progress of T cell anti-tumor function regulated by endoplasmic reticulum stress[J]. Journal of China Pharmaceutical University, 2022, 53(5): 518-524. DOI: 10.11665/j.issn.1000-5048.20220502
    [3]LUO Jianhua, XIA Xuefei, YAO Wenbing, TIAN Hong. Design and antitumor effect of nitrated T helper cell epitope vaccine CD47-NitraTh[J]. Journal of China Pharmaceutical University, 2019, 50(5): 614-621. DOI: 10.11665/j.issn.1000-5048.20190516
    [4]NING Hongyu, JIANG Tao, ZHANG Rui, HE Yu, YAO Wenbing, TIAN Hong. Effects of immunogenic HER2 on the differentiation of T-cell in mouse[J]. Journal of China Pharmaceutical University, 2018, 49(1): 102-108. DOI: 10.11665/j.issn.1000-5048.20180115
    [5]CHEN Yucong, GUO Wei, LEI Wen, GE Yaoyao, XUE Wenyao, LI Qianwen, GAO Xiangdong. Optimization of in vitro human follicular helper T cell differentiation condition[J]. Journal of China Pharmaceutical University, 2017, 48(6): 733-737. DOI: 10.11665/j.issn.1000-5048.20170616
    [6]WANG Chen, GUO Wei, WANG Xin, YU Dongmei, WANG Yuheng, YAO Wenbing. Condition of human Th17 cell differentiation induced in vitro[J]. Journal of China Pharmaceutical University, 2016, 47(1): 106-111. DOI: 10.11665/j.issn.1000-5048.20160116
    [7]CUI Ye, WANG Lu, SUN Qiong, ZHANG Can. In vitro evaluation of cationic liposomes prepared with oligopeptide-based lipids for plasmid DNA delivery[J]. Journal of China Pharmaceutical University, 2013, 44(4): 328-333. DOI: 10.11665/j.issn.1000-5048.20130408
    [8]Preparation of aFGF liposomes and their release behavior in vitro[J]. Journal of China Pharmaceutical University, 2010, 41(3): 248-252.
    [9]Effects of Epimedium Pubescens Flavonoids on Osteoblasts in vitro[J]. Journal of China Pharmaceutical University, 2002, (1): 50-52.
    [10]Study on the Preparation and Properties in Vitro of Fluorouracil Albumin Microspheres[J]. Journal of China Pharmaceutical University, 1999, (5): 353-356.

Catalog

    Get Citation
    PDF
    XML
    Article views (946) PDF downloads (1452) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：300501

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return